ArticleTherapeutics and clinical risk management2019

Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis.

Dejene Shiferaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.